Radiotherapy Market By Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy), By End User (Hospitals and Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global radiotherapy market was valued at $6,484.3 million in 2021, and is projected to reach $11,945.03 million by 2031, registering a CAGR of 6.3% from 2022 to 2031.
Radiotherapy is also known as radiation therapy, which utilizes high-energy radiation to kill cancer cells and reduce the size of tumor. It involves the use of various rays, including X-rays, gamma rays, and charged particles. During radiotherapy, radiation can be delivered to the body tissues internally as well as externally. According to the National Cancer Institute, around half of all the cancer patient population receives some type of radiation therapy during their treatment.
The market is driven by growth in number of cancer patients, increase in geriatric population, rise in adoption of radiotherapy devices and procedures, surge in number of awareness campaigns about the benefits of radiotherapy, and technological advancements in radiotherapy devices. However, lack of skilled personnel and difficulty in tumor visualization restrict the market growth. Conversely, growth opportunities in emerging markets and rise in demand for cancer treatment are expected to provide several opportunities for market growth during the forecast period.
According to the report of National Cancer Institute 2020, an estimated 1,806,590 new cases of cancer diagnosed in the U.S. and 606,520 people died from the disease in 2020. Prostate, lung, and colorectal cancers account for an estimated 43% of all cancers diagnosed in men in 2020. For women, the three most common cancers are breast, lung, and colorectal, and accounted for an estimated 50% of all new cancer diagnoses in women in 2020. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million.
The radiotherapy market is segmented on the basis of type, end user, and region. By type, it is divided into external beam radiotherapy therapy, internal radiotherapy/brachytherapy, and systemic radiotherapy. On the basis of end user, it is categorized into hospitals & clinics and Others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in the radiotherapy market include Accuray Incorporated, Becton, Dickinson and Company, Elekta AB, IBA (Ion Beam Applications SA), Isoray Medical Inc., Eckert & Ziegler Group, ICAD INC., Nordion, Inc., Siemens Healthineers and Mevion Medical Systems, Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis, current trends, and future estimations of the market to elucidate the imminent investment pockets.
It provides a quantitative analysis from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on products helps understand the type of devices used to treat diabetic problems.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Key players and their strategies are analysed to understand the competitive outlook of the overall market.
Market analysis is conducted by following key product positioning and monitoring the top contenders within the market framework.
Key Market Segments
By Type
External Beam Radiation Therapy
Internal Radiation Therapy
Systemic Radiation Therapy
By End User
Hospitals and Clinics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Accuray Incorporated
Eckert & Ziegler Group
Elekta AB
Ion Beam Applications SA
Becton, Dickinson and Company
ICAD INC.
ISORAY, INC.
MEVION MEDICAL SYSTEMS, INC.
Siemens Healthineers
NORDION INC.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: RADIOTHERAPY MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 External Beam Radiation Therapy
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Internal Radiation Therapy
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Systemic Radiation Therapy
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: RADIOTHERAPY MARKET, BY END USER
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Hospitals and Clinics
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Others
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- CHAPTER 6: RADIOTHERAPY MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Type
- 6.2.3 North America Market size and forecast, by End User
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Type
- 6.2.4.1.2 Market size and forecast, by End User
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Type
- 6.2.4.2.2 Market size and forecast, by End User
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Type
- 6.2.4.3.2 Market size and forecast, by End User
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Type
- 6.3.3 Europe Market size and forecast, by End User
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Type
- 6.3.4.1.2 Market size and forecast, by End User
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Type
- 6.3.4.2.2 Market size and forecast, by End User
- 6.3.4.3 U.K.
- 6.3.4.3.1 Market size and forecast, by Type
- 6.3.4.3.2 Market size and forecast, by End User
- 6.3.4.4 Italy
- 6.3.4.4.1 Market size and forecast, by Type
- 6.3.4.4.2 Market size and forecast, by End User
- 6.3.4.5 Spain
- 6.3.4.5.1 Market size and forecast, by Type
- 6.3.4.5.2 Market size and forecast, by End User
- 6.3.4.6 Rest of Europe
- 6.3.4.6.1 Market size and forecast, by Type
- 6.3.4.6.2 Market size and forecast, by End User
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Type
- 6.4.3 Asia-Pacific Market size and forecast, by End User
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 Japan
- 6.4.4.1.1 Market size and forecast, by Type
- 6.4.4.1.2 Market size and forecast, by End User
- 6.4.4.2 China
- 6.4.4.2.1 Market size and forecast, by Type
- 6.4.4.2.2 Market size and forecast, by End User
- 6.4.4.3 Australia
- 6.4.4.3.1 Market size and forecast, by Type
- 6.4.4.3.2 Market size and forecast, by End User
- 6.4.4.4 India
- 6.4.4.4.1 Market size and forecast, by Type
- 6.4.4.4.2 Market size and forecast, by End User
- 6.4.4.5 South Korea
- 6.4.4.5.1 Market size and forecast, by Type
- 6.4.4.5.2 Market size and forecast, by End User
- 6.4.4.6 Rest of Asia-Pacific
- 6.4.4.6.1 Market size and forecast, by Type
- 6.4.4.6.2 Market size and forecast, by End User
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Type
- 6.5.3 LAMEA Market size and forecast, by End User
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Brazil
- 6.5.4.1.1 Market size and forecast, by Type
- 6.5.4.1.2 Market size and forecast, by End User
- 6.5.4.2 Saudi Arabia
- 6.5.4.2.1 Market size and forecast, by Type
- 6.5.4.2.2 Market size and forecast, by End User
- 6.5.4.3 South Africa
- 6.5.4.3.1 Market size and forecast, by Type
- 6.5.4.3.2 Market size and forecast, by End User
- 6.5.4.4 Rest of LAMEA
- 6.5.4.4.1 Market size and forecast, by Type
- 6.5.4.4.2 Market size and forecast, by End User
- CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
- CHAPTER 8: COMPANY PROFILES
- 8.1 Accuray Incorporated
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 Eckert & Ziegler Group
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Elekta AB
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 Ion Beam Applications SA
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 Becton, Dickinson and Company
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 ICAD INC.
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 ISORAY, INC.
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 MEVION MEDICAL SYSTEMS, INC.
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Siemens Healthineers
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 NORDION INC.
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 2. RADIOTHERAPY MARKET SIZE, FOR EXTERNAL BEAM RADIATION THERAPY, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. RADIOTHERAPY MARKET FOR EXTERNAL BEAM RADIATION THERAPY BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. RADIOTHERAPY MARKET SIZE, FOR INTERNAL RADIATION THERAPY, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. RADIOTHERAPY MARKET FOR INTERNAL RADIATION THERAPY BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. RADIOTHERAPY MARKET SIZE, FOR SYSTEMIC RADIATION THERAPY, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. RADIOTHERAPY MARKET FOR SYSTEMIC RADIATION THERAPY BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. GLOBAL RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 9. RADIOTHERAPY MARKET SIZE, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. RADIOTHERAPY MARKET FOR HOSPITALS AND CLINICS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. RADIOTHERAPY MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. RADIOTHERAPY MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. RADIOTHERAPY MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. NORTH AMERICA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 15. NORTH AMERICA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 16. NORTH AMERICA RADIOTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. U.S. RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 18. U.S. RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 19. CANADA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 20. CANADA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 21. MEXICO RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 22. MEXICO RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 23. EUROPE RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 24. EUROPE RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 25. EUROPE RADIOTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. GERMANY RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 27. GERMANY RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 28. FRANCE RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 29. FRANCE RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 30. U.K. RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 31. U.K. RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 32. ITALY RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 33. ITALY RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 34. SPAIN RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 35. SPAIN RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 36. REST OF EUROPE RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 37. REST OF EUROPE RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 39. ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 40. ASIA-PACIFIC RADIOTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 41. JAPAN RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 42. JAPAN RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 43. CHINA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 44. CHINA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 45. AUSTRALIA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 46. AUSTRALIA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 47. INDIA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 48. INDIA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 49. SOUTH KOREA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 50. SOUTH KOREA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 51. REST OF ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 52. REST OF ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 53. LAMEA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 54. LAMEA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 55. LAMEA RADIOTHERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 56. BRAZIL RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 57. BRAZIL RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 58. SAUDI ARABIA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 59. SAUDI ARABIA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 60. SOUTH AFRICA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 61. SOUTH AFRICA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 62. REST OF LAMEA RADIOTHERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 63. REST OF LAMEA RADIOTHERAPY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 64.ACCURAY INCORPORATED: COMPANY SNAPSHOT
- TABLE 65.ACCURAY INCORPORATED: OPERATING SEGMENTS
- TABLE 66.ACCURAY INCORPORATED: PRODUCT PORTFOLIO
- TABLE 67.ACCURAY INCORPORATED: NET SALES,
- TABLE 68.ACCURAY INCORPORATED: KEY STRATERGIES
- TABLE 69.ECKERT & ZIEGLER GROUP: COMPANY SNAPSHOT
- TABLE 70.ECKERT & ZIEGLER GROUP: OPERATING SEGMENTS
- TABLE 71.ECKERT & ZIEGLER GROUP: PRODUCT PORTFOLIO
- TABLE 72.ECKERT & ZIEGLER GROUP: NET SALES,
- TABLE 73.ECKERT & ZIEGLER GROUP: KEY STRATERGIES
- TABLE 74.ELEKTA AB: COMPANY SNAPSHOT
- TABLE 75.ELEKTA AB: OPERATING SEGMENTS
- TABLE 76.ELEKTA AB: PRODUCT PORTFOLIO
- TABLE 77.ELEKTA AB: NET SALES,
- TABLE 78.ELEKTA AB: KEY STRATERGIES
- TABLE 79.ION BEAM APPLICATIONS SA: COMPANY SNAPSHOT
- TABLE 80.ION BEAM APPLICATIONS SA: OPERATING SEGMENTS
- TABLE 81.ION BEAM APPLICATIONS SA: PRODUCT PORTFOLIO
- TABLE 82.ION BEAM APPLICATIONS SA: NET SALES,
- TABLE 83.ION BEAM APPLICATIONS SA: KEY STRATERGIES
- TABLE 84.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 85.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 86.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 87.BECTON, DICKINSON AND COMPANY: NET SALES,
- TABLE 88.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
- TABLE 89.ICAD INC.: COMPANY SNAPSHOT
- TABLE 90.ICAD INC.: OPERATING SEGMENTS
- TABLE 91.ICAD INC.: PRODUCT PORTFOLIO
- TABLE 92.ICAD INC.: NET SALES,
- TABLE 93.ICAD INC.: KEY STRATERGIES
- TABLE 94.ISORAY, INC.: COMPANY SNAPSHOT
- TABLE 95.ISORAY, INC.: OPERATING SEGMENTS
- TABLE 96.ISORAY, INC.: PRODUCT PORTFOLIO
- TABLE 97.ISORAY, INC.: NET SALES,
- TABLE 98.ISORAY, INC.: KEY STRATERGIES
- TABLE 99.MEVION MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
- TABLE 100.MEVION MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
- TABLE 101.MEVION MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
- TABLE 102.MEVION MEDICAL SYSTEMS, INC.: NET SALES,
- TABLE 103.MEVION MEDICAL SYSTEMS, INC.: KEY STRATERGIES
- TABLE 104.SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
- TABLE 105.SIEMENS HEALTHINEERS: OPERATING SEGMENTS
- TABLE 106.SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
- TABLE 107.SIEMENS HEALTHINEERS: NET SALES,
- TABLE 108.SIEMENS HEALTHINEERS: KEY STRATERGIES
- TABLE 109.NORDION INC.: COMPANY SNAPSHOT
- TABLE 110.NORDION INC.: OPERATING SEGMENTS
- TABLE 111.NORDION INC.: PRODUCT PORTFOLIO
- TABLE 112.NORDION INC.: NET SALES,
- TABLE 113.NORDION INC.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.RADIOTHERAPY MARKET SEGMENTATION
- FIGURE 2.RADIOTHERAPY MARKET,2021-2031
- FIGURE 3.RADIOTHERAPY MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.RADIOTHERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.RADIOTHERAPY MARKET,BY TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF EXTERNAL BEAM RADIATION THERAPY RADIOTHERAPY MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INTERNAL RADIATION THERAPY RADIOTHERAPY MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SYSTEMIC RADIATION THERAPY RADIOTHERAPY MARKET,2021-2031(%)
- FIGURE 16.RADIOTHERAPY MARKET,BY END USER,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS RADIOTHERAPY MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS RADIOTHERAPY MARKET,2021-2031(%)
- FIGURE 19.RADIOTHERAPY MARKET BY REGION,2021
- FIGURE 20.U.S. RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 21.CANADA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 22.MEXICO RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 23.GERMANY RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 24.FRANCE RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 25.U.K. RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 26.ITALY RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 27.SPAIN RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 28.REST OF EUROPE RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 29.JAPAN RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 30.CHINA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 31.AUSTRALIA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 32.INDIA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 33.SOUTH KOREA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF ASIA-PACIFIC RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 35.BRAZIL RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 36.SAUDI ARABIA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 37.SOUTH AFRICA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 38.REST OF LAMEA RADIOTHERAPY MARKET,2021-2031($MILLION)
- FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 43.COMPETITIVE DASHBOARD
- FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 45.ACCURAY INCORPORATED.: NET SALES ,($MILLION)
- FIGURE 46.ECKERT & ZIEGLER GROUP.: NET SALES ,($MILLION)
- FIGURE 47.ELEKTA AB.: NET SALES ,($MILLION)
- FIGURE 48.ION BEAM APPLICATIONS SA.: NET SALES ,($MILLION)
- FIGURE 49.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
- FIGURE 50.ICAD INC..: NET SALES ,($MILLION)
- FIGURE 51.ISORAY, INC..: NET SALES ,($MILLION)
- FIGURE 52.MEVION MEDICAL SYSTEMS, INC..: NET SALES ,($MILLION)
- FIGURE 53.SIEMENS HEALTHINEERS.: NET SALES ,($MILLION)
- FIGURE 54.NORDION INC..: NET SALES ,($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook